Status: current, Defined. Date: 31-Oct 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 677321000036113 | Jakavi (ruxolitinib 20 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 677331000036110 | Jakavi 20 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Jakavi 20 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Jakavi 20 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Jakavi 20 mg tablet | Is a | Jakavi | true | Inferred relationship | Some | ||
| Jakavi 20 mg tablet | Is a | ruxolitinib 20 mg tablet | true | Inferred relationship | Some | ||
| Jakavi 20 mg tablet | has intended active ingredient | ruxolitinib | true | Inferred relationship | Some | 1810629732 | |
| Jakavi 20 mg tablet | has Australian BoSS | ruxolitinib | true | Inferred relationship | Some | 1810629732 | |
| Jakavi 20 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1810629733 |
Reference Sets
Trade product unit of use reference set
FHIR